Advanced glycation end products modulate transcriptional regulation in mesangial cells

Kidney International

Volumn 50, Issue 4, 1996, Pages 1166-1172

  Iehara, Noriyuki ^b   Takeoka, Hiroya ^b   Yamada, Yoshihiko ^b   Kita, Toru ^b   Doi, Toshio ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; EXTRACELLULAR MATRIX; GLYCATION; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

EID: 0029845845     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.424     Document Type: Article

References (46)

1. VLASSARA H, BUCALA R, STRIKER L: Pathogenic effects of advanced glycosylation: Biochemical, biologic, and clinical inplications for diabetes and aging. Lab Invest 70:138-151, 1994
2. CERAMI A, VLASSARA H, BROWNLEE M: Glucose and aging. Once considered biologically inert, the body's most abundant sugar can permanently alter some proteins. In doing so it may contribute to age-associated declines in the functioning of cells and tissues. Sci Am 24:346-16664, 1987
3. DOI T, VLASSARA H, KIRSTEIN M, YAMADA Y, STRIKLR GE, STRIKER LJ: Recetor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci USA 89:2873-2877, 1992
4. SCHMIDT AM, VIANNA M, GERLACH M, BRETT J, RYAN J, KAO J, ESPOSITO C, HEGARTY H, HURLEY W, CLAUSS M, WANG F, PAN Y-CE, TSANG TC, STERN D: Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Client 267:14987-14997, 1991
5. VLASSARA H, BROWNLEE M, MANOGUE K, DINARELLO C, PASAGIAN A: Cachectin/TNF and IL-1 induced by glucose-modified proteins: Role in normal tissue remodeling. Science 240:1546-1548, 1988
6. KIRSTEIN M, ASTON C, HINTZ R, VLASSARA H: Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins. J Clin Invest 90:439-446, 1992
7. CROWLEY ST, BROWNLEE M, EDELSTEIN D, SATRIANO JA, MORI T, SINGHAL PC, SCHLONDORFF DO: Effects of noncnzymatic glycosylation of mesangial matrix on proliferation of mesangial cells. Diabetes 40:540-547, 1991
8. LEE AT, CERAMI A: Elevated glucose-6-phosphate levels are associated with plasmid mutations in vivo. Proc Natl Acad Sci USA 84:8311-8314, 1987
9. YAN SD, SCHMIDT AM, ANDERSON GM, ZHANG J, BRETT J, ZOU YS, PINSKY D, STERN D: Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269:9889-9897, 1994
10. JOHNSON RJ, IIDA H, ALPERS CE, MAJESKY MW, SCHWARTZ SM, PRITZL PP, GORDON K, GOWN AM: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. α-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 87:847-858, 1991
11. MACKAY K, STRIKER LJ, ELLIOT S, PINKERT CA, BRINSTER RL, STRIKER GE: Glomerular epithelial, mesangial, and endothelial cell lines from transgenic mice. Kidney Int 33:677-684, 1988
12. MAKITA Z, RADOFF S, RAYFIELD EJ, YANG Z, SKOLNIK E, FRIEDMAN EA: Clinical assessment and significance of advanced glycation in patients woth diabetic nephropathy. N Engl J Med 325:836-842, 1991
13. SKOLNIK EY, YANG Z, MAKITA Z, RADOFF S, KIRSTEIN M, VLASSARA H: Human and rat mesangial cell receptors for glucose-modified proteins: Potential role in kidney tissue remodelling and diabetic nephropathy. J Exp Med 174:931-939, 1991
14. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
15. OBERBÄUMER I, LAURENT M, SCHWARZ U, SAKURAI Y, YAMADA Y, VOGELI G, Voss T, SIEBOLD B, GLANVILLE RW, KUHN K: Amino acid sequence of the non-collagenous globular domain (NC1) of the α1(IV) chain of basement membrane collagen as derived from complementary DNA. Eur J Biochem 147:217-224, 1985
16. MIN B, STRAUCH AR, FOSTER DN: Nucleotide sequence of a mouse vascular smooth muscle alpha-actin cDNA. Nucl Acid Res 16:10374, 1988
17. DOI T, STRIKER LJ, KIMATA K, PETEN EP, YAMADA Y, STRIKER GE: Glomerulosclerosis in mice transgenic for growth hormone. Increased mesangial extracellular matrix is correlated with kidney mRNA levels. J Exp Med 173:1287-1290, 1991
18. BURBELO PD, UTANI A, PAN Z-Q, YAMADA Y: Cloning of the large subunit of activator 1 (replication factor C) reveals homology with bacterial DNA ligases. Proc Natl Acad Sci USA 90:11543-11547, 1993
19. MELTON DA, KRIEG PA, REBAGLIATI MR, MANIATIS T, ZINN K, GREEN MR: Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucl Acid Res 12:7035-7056, 1984
20. BURBELO PD, BRUGGEMAN LA, GABLIEL GC, KLOTMAN PE, YAMADA Y: Characterization of a cis-acting element required for efficient transcriptional activation of the collagen IV enhancer. J Biol Chem 266:22297-22302, 1991
21. LUKOW B, SCHUTZ G: CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucl Acid Res 15:5490, 1987
22. GORMAN C, MOFFAT LF, HOWARD BH: Recombinant genomes which express chloramphenicol acelyltransferase in mammalian cells. Mol Cell Biol 2:1044-1051, 1982
23. NEUMANN JR, MORENCY CA, RUSSIAN KO: A novel rapid assay for chloramphenicol acetyltransferase gene expression. BioTechniques 5:444-448, 1987
24. ROSENTHAL N: Identification of regulatory elements of cloned genes with functional assays. Meth Enzymol 152:704-720, 1987
25. BRITTEN RJ, GRAHAM DE, NEUFELD BR: Analysis of repeating DNA sequences by reassociation. Meth Enzymol 24:363-418, 1974
26. SOUTHERN EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98:503-517, 1975
27. KILLEN PD, BURBELO PD, MARTIN GR, YAMADA Y: Characterization of the promoter for the α1(IV) collagen gene. J Biol Chem 263:12310-12314, 1988
28. ROSSI P, DE CROMBRUGGHE B: Identification of a cell-specific transcriptional enhancer in the first intron of mouse α2(type I) collagen gene. Proc Natl Acad Sci USA 84:5590-5594, 1987
29. MIN B, FOSTER DN, STRAUCH AR: The 5′-flanking region of the mouse vascular smooth muscle α-actin gene contains evolutionarily conserved sequence motifs within a functional promoter. J Biol Chem 265:16667-16675, 1990
30. SAMBROOK J, FRITSCH E, MANIATIS T: Molecular Cloning: A Laboratory Manual (2nd ed). Cold Spring Harbor, Cold Spring Harbor Press, 1988, p 13
31. DIGNAM JD, LEVOVITZ RM, ROEDER RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mamalian nuclei. Nucl Acid Res 11:1475-1489, 1983
32. BRADFORD M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
33. CHODOSH LA: Mobility shift DNA-binding assay using gel electrophoresis, in Current Protocols in Molecular Biology. edited by AUSUBEL FM, BKENT R, KINGSTON RE, MOORE DD, SEIDMAN JG, SMITH JA, STRUHL K, New York, John Wiley & Sons, 1994, p 12.2.1
34. BIRD AP, SOUTHERN EM: Use of restriction enzymes to study eukaryonic DNA methylation: I. The methylation pattern in ribosomal DNA from Xenopus laevis. J Mol Biol 118:27-28, 1978
35. ZIYADEH FN: Renal tubular basement menbrane and collagen type IV in diabetes mellitus. Kidney Int 43:114-120, 1993
36. YANG CW, HATTORI M, VLASSARA H, HE CJ, CAROME MA, YAMATO E, ELLIOT S, SIRIKER LJ: Overexpression of transforming growth factor-beta 1 mRNA is associated with up-regulation of glomerular tenascin and laminin gene expression in nonobese diabetic mice. J Am Soc Nephrol 5:1610-1617, 1995
37. MONNIER VM, SELL DR, NAGARAJ RH, MIYATA S, GRANDHEE S, ODETTI P, IBRAHIM SA: Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia. Diabetes 41(Suppl 2):36-41, 1992
38. YANG CW, VLASSARA H, PETEN EP, HE CJ, STRIKER GE, STRIKER LJ: Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci USA 91:9436-9440, 1994
39. MCKEON C, OHKUBO H, PASTAN I, DE CROMBRUGGHE B: Unusual methylation pattern of the α2(I) collagen gene. Cell 29:203-210, 1982
40. WETTZMAN SA, TURK PW, MILKOWSKI DH, KOZLOWSKI K: Free radical adductos induce alterations in DNA cytosine methylation. Proc Natl Acad Sci USA 91:1261-1264, 1994
41. IEHARA N, TAKEOKA H, TSUJI H, IMABAYASHI T, FOSTER DN, STRAUCH AR, YAMADA Y, KITA T, DOI T: Differentiation of smooth muscle phenotypes in mouse mesangial cells. Kidney Int 49:1330-1341, 1996
42. PUTTEN VV, LI X, MASELLI J, NEMENOFF RA: Regulation of smooth muscle α-actin promoter by vasopressin and platelet-derived growth factor in rat aortic vascular smooth muscle cells. Circ Res 75:1126-1130, 1994
43. SEAQUIST ER, GOETZ FC, RICH S, BARBOSA J: Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility lo diabetic nephropathy. N Engl J Med 320:1161-1165, 1989
44. MAKITA Z, RADOFF S, RAYFIELD EJ, YANG Z, SKOENIK E, DELANEY V, FRIEDMAN EA, CERAMI A, VLASSARA H: Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325:836-842, 1991
45. SOULIS-LIPAROTA T, COOPER M, PAPAZOGLOU D, CLARKE B, JERUMS G: Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat. Diabetes 40:1328-1334, 1991
46. EL KHOURY J, THOMAS CA, LOIKE JD, HICKMAN SF, CAO L, SILVERSTEIN SC: Macrophages adhere to glucose-modified basement membrane collagen IV via their scavenger receptors. J Biol Chem 269:10197-10200, 1994